CA2417669A1 - Methodes de differenciation des types de demence - Google Patents

Methodes de differenciation des types de demence Download PDF

Info

Publication number
CA2417669A1
CA2417669A1 CA002417669A CA2417669A CA2417669A1 CA 2417669 A1 CA2417669 A1 CA 2417669A1 CA 002417669 A CA002417669 A CA 002417669A CA 2417669 A CA2417669 A CA 2417669A CA 2417669 A1 CA2417669 A1 CA 2417669A1
Authority
CA
Canada
Prior art keywords
differentiating
methods
diseases
synthase
demential diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002417669A
Other languages
English (en)
Other versions
CA2417669C (fr
Inventor
Mitsuhito Mase
Hiroya Nakau
Takashi Inui
Naomi Eguchi
Yoshihiro Urade
Kosuke Seiki
Hiroshi Oda
Hiroshi Nakajima
Nobuyuki Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Bioscience Institute
Japan Science and Technology Agency
Maruha Nichiro Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2417669A1 publication Critical patent/CA2417669A1/fr
Application granted granted Critical
Publication of CA2417669C publication Critical patent/CA2417669C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une méthode de différenciation de maladies liées à la démence. Cette méthode consiste à mesurer la concentration de la prostaglandine D synthase de type lipocaline humaine dans un échantillon de fluide corporel prélevé sur un sujet. L'invention se rapporte également à une trousse permettant de différencier les maladies liées à la démence et contenant un anticorps spécifique à la prostaglandine D synthase de type lipocaline humaine.
CA002417669A 2000-07-21 2001-06-07 Methodes de differenciation des types de demence Expired - Fee Related CA2417669C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-221248 2000-07-21
JP2000221248 2000-07-21
PCT/JP2001/004811 WO2002008756A1 (fr) 2000-07-21 2001-06-07 Methode de differenciation de maladies liees a la demence

Publications (2)

Publication Number Publication Date
CA2417669A1 true CA2417669A1 (fr) 2003-01-21
CA2417669C CA2417669C (fr) 2009-09-15

Family

ID=18715694

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002417669A Expired - Fee Related CA2417669C (fr) 2000-07-21 2001-06-07 Methodes de differenciation des types de demence

Country Status (4)

Country Link
US (1) US7314727B2 (fr)
JP (1) JP3752219B2 (fr)
CA (1) CA2417669C (fr)
WO (1) WO2002008756A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408333A3 (fr) * 2001-10-03 2006-10-25 Pfizer Products Inc. Diagnostic et traitement de la maladie d'Alzheimer
JP3897117B2 (ja) * 2003-09-24 2007-03-22 マルハ株式会社 妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
JP4354954B2 (ja) * 2003-09-26 2009-10-28 株式会社マルハニチロ水産 関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
JP5543310B2 (ja) * 2010-09-29 2014-07-09 富士フイルム株式会社 イムノクロマトグラフ検査方法および装置
WO2014066568A1 (fr) 2012-10-24 2014-05-01 Winthrop-University Hospital Biomarqueur non invasif permettant d'identifier des sujets risquant un accouchement avant terme
EP3682250A4 (fr) 2017-09-13 2021-03-03 Progenity, Inc. Biomarqueurs de pré-éclampsie ainsi que systèmes et procédés associés
JP6607655B1 (ja) * 2017-12-28 2019-11-20 学校法人兵庫医科大学 リポカリン型プロスタグランジンｄ２合成酵素産生促進剤
EP4070113A4 (fr) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Évaluation de la prééclampsie à l'aide de dosages du facteur de croissance placentaire libre et dissocié

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458549B2 (en) 1998-06-11 2002-10-01 Winthrop-University Hospital Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same

Also Published As

Publication number Publication date
WO2002008756A1 (fr) 2002-01-31
JP3752219B2 (ja) 2006-03-08
US20030190678A1 (en) 2003-10-09
CA2417669C (fr) 2009-09-15
US7314727B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
Bondonno et al. Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial
IL142647A0 (en) A method and kit for measuring proteasome activity
WO2006117689A3 (fr) Methode de diagnostic de la sclerose en plaques
CA2417669A1 (fr) Methodes de differenciation des types de demence
WO2005008216A3 (fr) Collecte de fluides biologiques, application, dispositif de stockage et leurs procedes d'utilisation
EP1619206A3 (fr) Inhibiteur tissulaire des métalloprotéinases matricielles du type 1 (TIMP-1) comme marqueur du cancer
WO2005124365A3 (fr) Cuvette tronconique et procede de collecte de particules magnetiques
EA200601187A1 (ru) Стволовые клетки
NO20054119L (no) Kjemisk behandling av biologiske prover for nukleinsyreekstraksjon og kit for dette
IL166539A (en) Method for diagnosing multiple sclerosis
CA2366514A1 (fr) Utilisation a des fins diagnostiques et therapeutiques d'anticorps diriges contre le recepteur de l'urokinase
Ganter et al. Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients
WO2004013603A3 (fr) Procede de preparation d'echantillons pour sondes atomiques et source de prelevements
AU6842900A (en) Congener independent detection of microcystin and nodularin congeners
AU3784697A (en) Container for measurement of cell functions, kit for measurement of cell functions and method for measuring cell functions
DE60136665D1 (de) Verfahren zur Erkennung eines ganzen Homocysteins
CA2520438A1 (fr) Reactif au latex pour analyse d'adiponectine et procede d'analyse d'adiponectine
ATE472102T1 (de) Verfahren zur vorhersage von anomalien des lipidmetabolismus
EP1342791A3 (fr) Réagent, Procédé et appareil pour mesurer l'activité d'amylase
EP0315058A3 (fr) Procédé pour l'auto-exécution de cinétiques enzymatiques
Okano-Mitani et al. Leukotriene A 4 hydrolase in peripheral leukocytes of patients with atopic dermatitis
JPH04355339A (ja) 微量検体採取用具
AU2001289707A1 (en) Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms
FR2846009B1 (fr) Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
CN111856011B (zh) 一种检测丝氨酸羟甲基转移酶活性的试剂盒以及检测方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed